These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25188452)

  • 1. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006647. PubMed ID: 25188452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006647. PubMed ID: 21249679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
    van Dalen EC; Raphaël MF; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006647. PubMed ID: 19160293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
    de Baat EC; Mulder RL; Armenian S; Feijen EA; Grotenhuis H; Hudson MM; Mavinkurve-Groothuis AM; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014638. PubMed ID: 36162822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD009219. PubMed ID: 27669661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
    Li X; Xu S; Tan Y; Chen J
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010432. PubMed ID: 26037486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective interventions for cancer patients receiving anthracyclines.
    van Dalen EC; Caron HN; Dickinson HO; Kremer LC
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003917. PubMed ID: 15674919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
    Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
    Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective interventions for cancer patients receiving anthracyclines.
    van Dalen EC; Caron HN; Dickinson HO; Kremer LC
    Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD003917. PubMed ID: 21678342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.
    van Dalen EC; van der Pal HJ; Kremer LC
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD005008. PubMed ID: 26938118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
    van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.